A satellite symposium titled ‘CAR T Therapy: The NEX-T Frontier in MS’ was held at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). The symposium discussed current unmet needs and future advances in the management of multiple sclerosis (MS). Underlying the symposium was the importance of early intervention with disease-modifying therapy (DMT) in people with MS.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles


